Edition:
United States

DiaSorin SpA (DIAS.MI)

DIAS.MI on Milan Stock Exchange

86.85EUR
17 Aug 2018
Change (% chg)

€0.30 (+0.35%)
Prev Close
€86.55
Open
€86.85
Day's High
€87.10
Day's Low
€86.15
Volume
30,505
Avg. Vol
84,668
52-wk High
€99.20
52-wk Low
€65.05

Chart for

About

DiaSorin SpA is an Italy-based company engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease,... (more)

Overall

Beta: 0.41
Market Cap(Mil.): €4,931.39
Shares Outstanding(Mil.): 55.95
Dividend: 1.80
Yield (%): 0.98

Financials

  DIAS.MI Industry Sector
P/E (TTM): 30.83 37.48 30.17
EPS (TTM): 2.81 -- --
ROI: 21.89 14.29 12.67
ROE: 23.98 17.46 14.86

BRIEF-Diasorin Receives FDA Clearance For Liaison Brahms Percent II Gen Assay For Sepsis

* RECEIVES FDA CLEARANCE FOR LIAISON BRAHMS PERCENT II GEN ASSAY TO DETECT SEVERE BACTERIAL INFECTIONS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Apr 05 2018

BRIEF-DiaSorin Earns FDA Clearance Extending Sample Claims For HSV 1 & 2 Test

* EARNS FDA CLEARANCE EXTENDING SAMPLE CLAIMS FOR SIMPLEXA HSV 1 & 2 DIRECT MOLECULAR TEST

Mar 28 2018

BRIEF-DiaSorin FY Net Profit Up At EUR 139.9 Mln

* FY REVENUE EUR 637.5 MILLION VERSUS EUR 569.3 MILLION YEAR AGO

Mar 07 2018

Earnings vs. Estimates